![](https://cancer.uillinois.edu/wp-content/uploads/2022/06/6-27-22-Onclive-Gadi2.png)
HER2 Dual Blockade in Early Stage HER2+ Breast Cancer
Dr. VK Gadi and an expert panel of oncologists share insight on the optimal use of HER2 dual-blockade strategies in patients with early-stage HER2+ breast cancer.
![](https://cancer.uillinois.edu/wp-content/uploads/2021/08/OncLive_2013_SAP_Seal.jpg)
The University of Illinois Cancer Center serves as a Strategic Alliance Partner with OncLive. View our complete video library.